Enalapril Hctz Austell 20/12,5 mg, Tablets
PDF Leaflet Revision Date: 23 December 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension where combination therapy is preferred.
Dosage (summary)
1 tablet once daily, may increase to 2 tablets if needed.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity
- Anuria
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Hypotension
- Cough
- Dizziness
- Hyperkalaemia
Counselling Points
- Monitor blood pressure regularly
- Report any signs of swelling or difficulty breathing
- Avoid potassium supplements
Serious warnings
- Risk of angioedema
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Enalapril Hctz Austell 20/12,5 mg, Tablets professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
